Keith J Roberts
Overview
Explore the profile of Keith J Roberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
1440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rompen I, Stoop T, van Roessel S, van Veldhuisen E, Janssen Q, Alseidi A, et al.
Ann Surg
. 2025 Jan;
PMID: 39886770
Aim: To validate the prognostic value of the PAncreatic NeoAdjuvant MAssachusetts (PANAMA)-score and to determine its predictive ability for survival benefit derived from adjuvant treatment in patients after resection of...
2.
Labib P, Russell T, Denson J, Puckett M, Ausania F, Pando E, et al.
HPB (Oxford)
. 2025 Jan;
PMID: 39870557
Background: Most patients undergoing pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) develop recurrence. No previous studies have investigated predictors of local-only recurrence following PD for PDAC. Our study aimed to...
3.
Stoop T, Sugawara T, Oba A, Feld I, van Roessel S, van Veldhuisen E, et al.
JAMA Oncol
. 2025 Jan;
PMID: 39847363
Importance: The effect of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative (m)FOLFIRINOX (combination leucovorin calcium [folinic acid], fluorouracil, irinotecan hydrochloride, and oxaliplatin in full or modified dosing) chemotherapy...
4.
Uijterwijk B, Moekotte A, Boggi U, Mazzola M, Groot Koerkamp B, Dalle Valle R, et al.
HPB (Oxford)
. 2025 Jan;
27(3):318-329.
PMID: 39765373
Background: Ampullary adenocarcinoma (AAC) typically presents at an early stage due to biliary obstruction and therefore might be specifically suitable for minimally invasive pancreatoduodenectomy (MIPD). However, studies assessing MIPD specifically...
5.
Cardoso S, Clarke G, Nayak A, Joshi K, Sudereyan R, Karkhanis S, et al.
HPB (Oxford)
. 2024 Dec;
27(3):299-310.
PMID: 39690102
Background: Two-staged hepatectomy (TSH) with portal (PVE) or dual vein embolization (DVE) gained acceptance in liver surgery. The current study assesses the incidence and causes of failure to progress to...
6.
Olthof P, Bouwense S, Bednarsch J, Dewulf M, Kazemier G, Maithel S, et al.
Ann Surg Oncol
. 2024 Oct;
32(3):1762-1768.
PMID: 39404989
Background: Failure to rescue (FTR) is defined as the inability to prevent death after the development of a complication. FTR is a parameter in evaluating multidisciplinary postoperative complication management. The...
7.
Halle-Smith J, Leung P, Hall L, Aksin M, van Laarhoven S, Skipworth J, et al.
HPB (Oxford)
. 2024 Oct;
26(12):1536-1543.
PMID: 39384505
Introduction: Pathological response of pancreatic ductal adenocarcinoma (PDAC) to neoadjuvant chemotherapy (NAT) has been associated with oncological outcome. The aim of the study was to investigate factors associated with favourable...
8.
Alnagar A, Zakeri N, Koilias K, Faulkes R, Brown R, Cain O, et al.
World J Transplant
. 2024 Sep;
14(3):95849.
PMID: 39295983
Background: Recurrence of hepatocellular carcinoma (HCC) following liver transplantation (LT) has a devastating influence on recipients' survival; however, the risk of recurrence is not routinely stratified. Risk stratification is vital...
9.
Hall L, Loader D, Gouveia S, Burak M, Halle-Smith J, Labib P, et al.
World J Gastrointest Surg
. 2024 Sep;
16(8):2689-2701.
PMID: 39220089
Background: The use of neoadjuvant therapy (NAT) in distal cholangiocarcinoma (dCCA) with regional arterial or extensive venous involvement, is not widely accepted and evidence is sparse. Aim: To synthesise evidence...
10.
Uijterwijk B, Moekotte A, Boggi U, Mazzola M, Groot Koerkamp B, Dalla Valle R, et al.
Ann Surg
. 2024 Sep;
PMID: 39219532
Objective: To compare minimally invasive and open pancreatoduodenectomy in different subtypes of ampullary adenocarcinoma. Summary Background Data: Ampullary adenocarcinoma (AAC) is widely seen as the best indication for minimally invasive...